Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

WOUNDSENS A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials

Coordinator
Evoenzyme SL, Spain
Runs
1 November 2023 to 31 October 2027
Status
Running
EU funding
€2.9m
Total cost
€2.9m
Partners
4 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101115337

What the project is doing

In the project's own words, from its summary on CORDIS.

Global healthcare associated with chronic non-healing wounds can be considered a main public health problem as affects up to 2% of the world population. A novel approach is needed mainly to support the quality of life of the people suffering from this silent epidemic and additionally, alleviate the impact in costs and resources for the healthcare system. Up to date, no smart bandages have made it to the real market and research state is still going on for a reliable and sensitive inspection method.

The main goal of WOUNDSENS project is to lead the development of a novel generation of wearable biosensors with a synergy of technological breakthroughs in transversal fields of knowledge. Sensor elements, for the first time, will directly become a compatible part of the wound dressing material itself resulting in enhanced wearing comfort and operability. Accordingly, they will be integratable into manufacturers' existing standard processes (suturing, embroidery, roll-to-roll).

Our proposal presents a parading shift in smart wound dressings constructed on novel hollow fibers with radial bio-signaling based on engineered novel enzymes. WOUNDSENS presents a leading-edge new technology with the design and development of innovative electrochemical materials with step forward advances in CONDUCTIVE MATERIAL, the development of electrospun neofibers and processes with leading edge methodologies on ELECTROSPINNING and the ENZYME ENGINEERING of a new family of detection biocatalysts (resurrected and extant enzymes) to secure a sensitive and reliable signal.

WOUNDSENS proposal accepts the challenge of pushing forward the new technological platform to design a new concept in continuous wound control and monitoring improving the life of millions of people.

Topics

Who is involved

OrganisationCityCountryRole
Evoenzyme SLMadridSpainCoordinator
Naturwissenschaftliches Und Medizinisches Institut an Der Universitaet TuebingenReutlingenGermanyParticipant
Centre National De La Recherche Scientifique CNRSParisFranceThird party
Universite De LorraineNancy CedexFranceParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI